News

Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease

Tppp3 is a novel molecule for retinal ganglion cell identification and optic nerve regeneration

3 Pittsburgh universities part of $125M quest for a working eye transplant

Pitt Team Gets Millions From ARPA-H for Whole Eye Transplant Project

What If We Could Cure Blindness?

Vision Leaders Reinforce Pittsburgh-Paris Partnership at i2Eye Conference

Blink | Looking for treatment for Mia, Colin, Laurent and all the others

Why You May Need New Glasses at Age 40

Recently Published Research from the Department of Ophthalmology

Just How Important Are Vision Tests for Young Kids? Very.

UPMC Vision Institute Begins Clinical Use of Luxturna® Gene Therapy for Inherited Retinal Dystrophies

Sisters who share a progressive eye disease find hope in a gene therapy right here in Pittsburgh

Pittsburgh’s José-Alain Sahel honored with Wolf Prize for groundbreaking research on sight restoration

UPMC Vision Institute treats sisters with rare genetic disorder robbing them of vision